<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cucca, A</style></author><author><style face="normal" font="default" size="100%">Stragapede, L</style></author><author><style face="normal" font="default" size="100%">Antonutti, L</style></author><author><style face="normal" font="default" size="100%">Catalan, M</style></author><author><style face="normal" font="default" size="100%">Caracciolo, I</style></author><author><style face="normal" font="default" size="100%">Valentinotti, Romina</style></author><author><style face="normal" font="default" size="100%">Granato, A</style></author><author><style face="normal" font="default" size="100%">D'Agaro, P</style></author><author><style face="normal" font="default" size="100%">Manganotti, P</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection.</style></title><secondary-title><style face="normal" font="default" size="100%">J Neurovirol</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Neurovirol.</style></alt-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2016 May 31</style></date></pub-dates></dates><language><style face="normal" font="default" size="100%">ENG</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;A 21-year-old woman presented with acute-onset spastic paraparesis. The MRI spinal scan revealed a contrast-enhanced T2 hyperintensity between C5-T2. The most common neurotropic pathogens were excluded by first level tests. Under suspicion of an acute immune-mediated myelitis, a corticosteroid therapy was administered. However, a seropositivity for both human immunodeficiency virus (HIV) type 1 and human T-lymphotropic virus (HTLV) subsequently emerged. An antiretroviral therapy was started while steroids discontinued. Patient's clinical conditions remained unchanged. HIV-HTLV-1 co-infection should be included in the differential diagnosis of any acute myelitis, even in patients with a preserved immune status and no risk factors.&lt;/p&gt;</style></abstract><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/27245591?dopt=Abstract</style></custom1></record></records></xml>